Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Construction and Evaluation of the Early Identification for Oxaliplatin Induced Portal Hypertension

NCT04524650 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT04524650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04524650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Construction and Evaluation of the Early Identification for Oxaliplatin Induced Portal Hypertension
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2020
Completion date
September 30, 2022
Enrollment
370 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, gastroesophageal varices, received oxaliplatin-based chemotherapy